Journal
CURRENT OPINION IN CARDIOLOGY
Volume 16, Issue 4, Pages 219-224Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001573-200107000-00001
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL03458] Funding Source: Medline
Ask authors/readers for more resources
Hypercholesterolemia has not traditionally been considered an important risk factor in the pathogenesis of stroke. However, recent studies show that statin therapy significantly reduces ischemic stroke for patients with established coronary artery disease. Statin therapy may reduce stroke through amelioration of precerebral atherosclerosis in the carotid artery and the aorta. Anti-atherosclerotic, anti-inflammatory, and antithrombotic actions of statins occur within the blood and in plaque. Statins may also protect against cerebral ischemia through beneficial modulation of the brain endothelial nitric oxide system. Ongoing studies are exploring the role of statin therapy in the primary prevention of stroke and in the prevention of cognitive decline and multi-infarct cerebrovascular disease. (C) 2001 Lippincott Williams & Wilkins, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available